| 发明名称 |
A Novel Compound for the Treatment of Hepatitis C |
| 摘要 |
The present invention provides (R)-5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamoyl)phenyl)-6-(sec-butyl)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.; |
| 申请公布号 |
US2016318912(A1) |
申请公布日期 |
2016.11.03 |
| 申请号 |
US201415103206 |
申请日期 |
2014.12.08 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
Yeung Kap-Sun;Grant-Young Katharine A. |
| 分类号 |
C07D413/12 |
主分类号 |
C07D413/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. The compound (R)-5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamoyl)phenyl)-6-(sec-butyl)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide, or a pharmaceutically acceptable salt thereof |
| 地址 |
Princeton NJ US |
